Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Relapse-remitting Multiple Sclerosis”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT03091569
What this trial is testing

Effects of Vitamin K on Redness Associated With Injection Site Reactions in Participants Treated With Plegridy

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 23
Testing effectiveness (Phase 2)Study completedNCT00207727
What this trial is testing

A Safety and Efficacy Study of CNTO1275 in Patients With Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Centocor, Inc. 249
Not applicableEnded earlyNCT00398528
What this trial is testing

An fMRI Study of Treatment Optimization Comparing Two Disease Modifying Therapies Used to Treat Relapsing Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Neurognostics 48
Not applicableStudy completedNCT03193866
What this trial is testing

COMparison Between All immunoTherapies for Multiple Sclerosis.

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Karolinska Institutet 3,526
Not applicableLooking for participantsNCT07376772
What this trial is testing

Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

Who this might be right for
Multiple Sclerosis (MS) - Relapsing-remittingUpper Extremity Dysfunction
University of Florida 15
Not applicableStudy completedNCT00229502
What this trial is testing

Cognitive Effects of Immunomodulatory Drugs in MS

Who this might be right for
Multiple Sclerosis
Sharon Lynch, MD 96
Testing effectiveness (Phase 2)Study completedNCT01111656
What this trial is testing

Efficacy, Safety and Tolerability of Atorvastatin 40 mg in Patients With Relapsing-remitting Multiple Sclerosis Treated With Interferon-beta-1b

Who this might be right for
Relapsing-remitting Multiple Sclerosis
Insel Gruppe AG, University Hospital Bern 28
Not applicableUnknownNCT05615454
What this trial is testing

Effect of Bio-electromagnetic Energy Regulation Therapy on Erectile Dysfunction in Patients With Multiple Sclerosis

Who this might be right for
Erectile Dysfunction Due to Diseases Classified ElsewhereMultiple Sclerosis, Relapsing-Remitting
Imam Abdulrahman Bin Faisal University 50
Post-approval studies (Phase 4)WithdrawnNCT02675413
What this trial is testing

Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-Remitting
Washington University School of Medicine
Post-approval studies (Phase 4)Study completedNCT02461069
What this trial is testing

Investigation of the Effect of Dimethyl Fumarate on T Cells in Patients With Relapsing Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
University Hospital Muenster 67
Post-approval studies (Phase 4)Study completedNCT00492466
What this trial is testing

Investigating if Interferon-Beta Can be Used in Patients With MS After They Have Developed Neutralizing Antibodies

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 14
Large-scale testing (Phase 3)Study completedNCT01064401
What this trial is testing

Efficacy and Safety of BIIB019 (Daclizumab High Yield Process) Versus Interferon β 1a in Participants With Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Biogen 1,841
Not applicableUnknownNCT05019248
What this trial is testing

Immune Response to Seasonal Influenza Vaccination in Multiple Sclerosis Patients Receiving Cladribine

Who this might be right for
Multiple Sclerosis, Relapsing-RemittingVaccine Response Impaired
Heinrich-Heine University, Duesseldorf 260
Early research (Phase 1)Study completedNCT01424462
What this trial is testing

Healthy Volunteer Pilot Study Using 3 Types of Modified Release Formulations of Firategrast to Investigate How Quickly Absorption From the Digestive System Takes Place.

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
GlaxoSmithKline 20
Not applicableStudy completedNCT00937677
What this trial is testing

Effect of Tysabri in Patients With Relapsing-Remitting Multiple Sclerosis: A Follow-up Magnetization Transfer Imaging (MTI) Study

Who this might be right for
Multiple Sclerosis
University at Buffalo 85
Not applicableUnknownNCT00210301
What this trial is testing

Combination Therapy (Provigil + Avonex) to Treat Cognitive Problems in MS

Who this might be right for
Relapsing-Remitting Multiple Sclerosis
Institute for Clinical Research 60
Not applicableLooking for participantsNCT06267781
What this trial is testing

RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies

Who this might be right for
Multiple Sclerosis
IRCCS San Raffaele 30
Not applicableLooking for participantsNCT06526364
What this trial is testing

Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)

Who this might be right for
Multiple SclerosisMultiple Sclerosis, Relapsing-RemittingMultiple Sclerosis, Primary Progressive+1 more
University Hospital, Basel, Switzerland 100
Post-approval studies (Phase 4)Study completedNCT01767493
What this trial is testing

Study to Evaluate the Feasibility of [18F]Florbetapir PET for Assessment in MS Patients

Who this might be right for
Multiple Sclerosis
Institute for Neurodegenerative Disorders 19
Large-scale testing (Phase 3)Study completedNCT00004814
What this trial is testing

Phase III Randomized, Double-Blind, Placebo-Controlled Study of Copolymer 1 for Relapsing-Remitting Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
National Center for Research Resources (NCRR) 250
Next Page